Fourteen Cases of Appetite Loss Treated with Shoyogan

  • FUKATANI Ryo
    Department of Internal Medicine, Kashima Rosai Hospital, Labour Welfare Corporation
  • SUGAO Masataka
    Department of Internal Medicine, Kashima Rosai Hospital, Labour Welfare Corporation
  • SHIMAZU Kengo
    Department of Internal Medicine, Kashima Rosai Hospital, Labour Welfare Corporation
  • CHIJIWA Takeharu
    Center of Japanese Oriental Medicine, Kashima Rosai Hospital, Labour Welfare Corporation
  • AOYAGI Haruhiko
    Department of Pharmacy, Kashima Rosai Hospital, Labour Welfare Corporation
  • OZAWA Tomoaki
    Department of Pharmacy, Kashima Rosai Hospital, Labour Welfare Corporation
  • SHIMADA Yutaka
    Department of Japanese Oriental Medicine, Toyama University Hospital
  • ITOH Takashi
    Center of Japanese Oriental Medicine, Kashima Rosai Hospital, Labour Welfare Corporation

Bibliographic Information

Other Title
  • 食欲不振14症例に対する薯蕷丸の治療効果に関する検討
  • 臨床報告 食欲不振14症例に対する薯蕷丸の治療効果に関する検討
  • リンショウ ホウコク ショクヨク フシン 14 ショウレイ ニ タイスル トロロマル ノ チリョウ コウカ ニ カンスル ケントウ

Search this article

Abstract

Shoyogan is a Kampo prescription described in the Junqui Yaolue. Few cases have been reported using this medicine. This time, we prescribed shoyogan for 14 patients who suffered from severe appetite loss. We had positive outcomes as follows. We administered shoyogan to 8 patients with malignant disease. Six of them suffered from lung cancer. Shoyogan was effective in these patients. Shoyogan was not effective for the other 2 patients, with bile duct carcinoma and malignant lymphoma. The dietary intake was increased from 28 percent of meals supplied to 79 percent in the appetite-improved group. We also administered shoyogan to 6 patients with nonmalignant disease. It was effective for 3 patients: 1 with congestive heart failure and 2 with great trochanteric fractures of the femur. It was not effective for the other 3 patients, who suffered from anorexia, pneumonia and depression associated with diabetes mellitus. Shoyogan seems to be effective for patients with terminal lung cancer and maintains their quality of life.

Journal

  • Kampo Medicine

    Kampo Medicine 62 (6), 727-735, 2011

    The Japan Society for Oriental Medicine

Citations (1)*help

See more

References(16)*help

See more

Details 詳細情報について

Report a problem

Back to top